Dr. Julie Olson Childers, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 700 Plaza Cir, Suite M, Clinton, SC 29325 Phone: 864-833-5673 Fax: 864-833-0484 |
Mrs. Kristin Rowland Derrick, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1208 Springdale Dr, Clinton, SC 29325 Phone: 864-833-5400 Fax: 864-833-5417 |
Dr. Dawn Sherer Reynolds, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 85 Professional Park Road, Clinton, SC 29325 Phone: 864-938-6002 Fax: 864-938-6589 |
Dr. Seth C Reynolds, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 85 Professional Park Road, Clinton, SC 29325 Phone: 864-938-6002 Fax: 864-938-6589 |
Dr. Gary Fowler Crow Sr., D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 23454 Highway 76 E, Clinton, SC 29325 Phone: 864-833-5793 Fax: 864-833-1590 |
Dr. Daniel P Hartley, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 103 Calvert Ave, Clinton, SC 29325 Phone: 864-833-5333 |
News Archive
Researchers at Fox Chase Cancer Center have demonstrated that it might be possible to treat genetic diseases, including some forms of cancer, by "rescuing" the misshapen, useless proteins produced by some mutant genes.
Researchers at the Kimmel Cancer Center at Jefferson have shed new light on the longstanding conundrum about what makes a tumor grow-and how to make it stop. Interestingly, cancer cells accelerate the aging of nearby connective tissue cells to cause inflammation, which ultimately provides "fuel" for the tumor to grow and even metastasize.
The high-dose flu vaccine is significantly better than the regular flu shot at boosting the immune response to the flu virus in frail, older residents of long-term care facilities, according to the results of a University of Pittsburgh School of Medicine study.
Medicare reimbursement rates should be based on how cost effective the treatment is for a particular illness, according to a piece by two policy experts in the October edition of Health Affairs.
Neurological researchers at Rush University Medical Center have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease. The target called neutral sphingomyelinase (N-SMase) is a protein that when activated, can cause a chain of reactions in the cell leading to neuronal death and memory loss.
› Verified 2 days ago